Add to Favorites Newsroom RSS Share
fb-shareDana-Farber Cancer Institute
Boston, MA USA

Our News on Newswise

Newswise: RameshShivdasaniMDPhD.jpg

Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

Researchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors – known as pNETs – that have dramatically different risks of recurrence following surgical treatment [or surgery]. The finding could yield predictive tests,...
3-Jul-2019 1:05 PM EDT Add to Favorites

High doses of 60-plus year-old chemotherapy drug found to spur immune system attack on lymphoma

Cyclophosphamide, a mainstay of chemotherapy for many cancers, acts as both chemotherapy and immunotherapy at high doses, study finds
28-Jun-2019 3:00 PM EDT Add to Favorites

Walking Speed Points to Future Clinical Outcomes for Older Patients with Blood Cancers

Researchers at Dana-Farber Cancer Institute and the VA Boston Healthcare System have uncovered a new vital sign for gauging survival and likelihood of having an unplanned hospitalization in older patients with blood cancers: the speed at which they...
5-Jun-2019 4:50 PM EDT Add to Favorites

Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer

Enzalutamide, an oral androgen receptor inhibitor, can improve outcomes for men with metastatic hormone-sensitive prostate cancer (mHSPC), according to a large study presented by Christopher Sweeney, MBBS of Dana-Farber Cancer Institute's Lank...
2-Jun-2019 6:30 AM EDT Add to Favorites

Newswise: PREFERREDDavidKwiatkowskiSOG_5268_18.jpg

Pre-surgical immunotherapy shows promise in trial for patients with early stage lung cancer

Pre-surgical immunotherapy shows promise in trial for patients with early stage lung cancer
30-May-2019 2:05 PM EDT Add to Favorites

Newswise: CatherineWuSOG_2037_17.jpg

Patterns of chronic lymphocytic leukemia growth identified

In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of...
29-May-2019 12:00 PM EDT Add to Favorites

Black Men Less Likely Than Nonblack Patients to Adopt Active Surveillance for Low-Risk Prostate Cancer

At a time when a growing number of men with prostate cancer considered “low risk” are opting for active surveillance or watchful waiting rather than immediate treatment with surgery or radiation, a new study reveals that black men are less...
21-May-2019 1:05 PM EDT Add to Favorites

Newswise: YawkeyBuilding.jpg

Dana-Farber researchers present findings in more than 70 research studies at ASCO annual meeting 2019

Dana-Farber Cancer Institute researchers are presenting more than 70 research studies at the 2019 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 31st- June 4th. ASCO is the world’s largest clinical cancer...
16-May-2019 3:05 PM EDT Add to Favorites


see all news

Our Experts on Newswise

Newswise: Dr.JeffreyMeyerhardtFINAL.jpg

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

Newswise: AnnPartridge.jpg

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

11-Nov-2013 5:00 PM EST

Newswise: PF_SOG_7837.jpg

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

17-Sep-2013 3:00 PM EDT

Newswise: Dr.Haddadphoto.jpg

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

Newswise: Andrea_Patenaude.jpg

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

24-May-2013 3:00 PM EDT

Newswise: Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

Healthy Holiday Helpings: Experts Offer Tips to Fight Cancer with Your Fork This Holiday Season

The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT

see all experts

Our YouTube Videos

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Contacts

Ellen Berlin
Media Relations Director

ellen_berlin@dfci.harvard.edu

617-632-5357

Robert Levy
Science Writer

robert_levy@dfci.harvard.edu

617-632-4090

Molly McHale
Associate Director for Communications

molly_mchale@dfci.harvard.edu

617-632-5675

Richard Saltus
Senior Science Writer

richard_saltus@dfci.harvard.edu

617-632-5643

Donna Walthall
Marketing Director

donna_walthall@dfci.harvard.edu

617-632-5856

Peter Cohenno
Senior Media Relations Specialist

Peter_Cohenno@dfci.harvard.edu

Claire Monaghan
Senior Media Relations Specialist
hematology

Claire_Monaghan@dfci.harvard.edu

617-632-5653

John Noble
Senior Media Relations Specialist
Health Care

johnw_noble@dfci.harvard.edu

617-632-5784

Quincey Spagnoletti
Media Relations Specialist

quinceym_spagnoletti@dfci.harvard.edu

315-720-2715

Victoria Warren
Media Relations Manager

Victoria_Warren@dfci.harvard.edu

617-582-9323

Twitter twitter-icon

Chat now!